LOS ANGELES--(EON: Enhanced Online News)--On Wednesday, November 6th, 41 emerging bioscience and digital health companies will present their innovations and business opportunities at the 15th Annual SoCalBio Investor & Partnership Conference, which will be held at the Omni Hotel in downtown Los Angeles.
“Firms focused on telehealth and mobile healthcare applications will make a very strong showing at this year’s conference. We’re likely to see even more of this in the years ahead given the relatively easy startup process for such companies and the changes occurring in technology and the business of healthcare.”
Produced by the Southern California Biomedical Council (SoCalBio), the conference is the only annual event of its kind in the Los Angeles region to showcase the latest advancements by bioscience firms seeking capital and partnership opportunities. The 41 companies selected to present this year focus on a wide range of technologies and market segments, including regenerative medicine, therapeutic devices, bio-pharmaceuticals, patient screening and monitoring, digital health and telemedicine.
Most of the companies are based locally. They were selected by a panel of 20 bioscience and investment industry professionals via a rigorous screening process that ran from May to November.
SoCalBio President Ahmed Enany noted this year’s surge in digital and telehealth companies making the list. "Firms focused on telehealth and mobile healthcare applications will make a very strong showing at this year’s conference. We’re likely to see even more of this in the years ahead given the relatively easy startup process for such companies and the changes occurring in technology and the business of healthcare."
This year’s list of presenting companies includes:
- Amicrobe (Advanced biomaterials with innovative product candidates designed to prevent and treat infections)
- AnaBios (Human-based drug response profiles in advance of clinical trials)
- Applied Biomedical (High accuracy disposable ambulatory infusion pumps)
- AQCI (Automated quality control instruments for nuclear pharmacies)
- Asta Fluidic Technologies (Fetomaternal hemorrhage diagnosis)
- BestDose (Software to personalize medication dosage)
- BioPhotas (Biophotonic-based treatment of musculoskeletal and dermatological conditions)
- Bone Rad Therapeutics (Bone tumors treatments)
- Bruin Biometrics (Wireless solutions for wound care, orthopedic care, real-time data capture, analytics and reporting)
- CaliCast (UCLA orthopedic cast technology)
- Conjunctival Monitor (L.A. Biomed spinoff with systems to monitor the conjunctiva for carbon dioxide and oxygen tensions and pH during cardiopulmonary procedures)
- DPS Health (Cost-effective behavioral change and self-management support programs)
- Dr. Marion Digital (Online apps to empower elderly care)
- Encode Bio (Compounds to treat inflammation and autoimmune diseases)
- Endeau Inc. (Instrument and equipment platforms for Water-Aided-Endoscopy)
- Hillhurst Biopharmaceuticals (Orally-delivered therapeutic for sickle cell disease)
- JET Lasik (Device combining a modified collagen-coated contact lens with a layer of live cultured skin cells to act as a postoperative tissue transplant “bandage” in photorefractive keratectomy procedures)
- Kulira (Tumor analysis medical devices)
- NanoValent (Drug delivery)
- Neural Analytics (Non-invasive intracranial pressure monitoring)
- Neu-Spine (Health wellness and fitness biofeedback system for lumbar stabilization)
- Onciomed (Minimally invasive obesity treatment devices)
- Otokinetics (Hearing implant for severe hearing loss)
- Mitochon Systems (Provides physician and patient communities with highly targeted contextual content, placed into the physician’s workflow, patient portal or digital health system)
- Perimeter Medical Imaging (Real time, actionable information for surgeons about tumor margins)
- PLC Diagnostics (Next generation handheld point-of-care diagnostic platform)
- QT Medical (LA BioMed spinoff developing pediatric devices)
- RTime.com (One-stop solutions for quality eldercare services, facilities and information)
- Sensor Jacket (Patented smart phone jacket with built-in infrared sensor for measuring vital signs)
- Sentire Medical Systems (Bowel perforation sensors)
- Skymedicus (Telemedicine platform for medical tourism)
- SnapMD (Telemedicine communications platform tailored for pediatrics)
- StemVax (Next-generation immunotherapy platform to treat brain cancer)
- Supervision (Real-time telesurgery)
- SynTouch (Biomimetic tactile sensing)
- Trend Shift (Health care data analytics)
- UCLA device for precise breast radiotherapy
- Val 9000 (Telemedicine platform for voice activated access to clinical information and patient monitoring)
- Viderics (Novel ultrasound-based devices for cardiovascular applications)
- Vitalix Biosciences (Mucormycosis treatment)
- ZD Medical (Devices for vascular imaging)
In addition to emerging company presentations, the SoCalBio Investor & Partnership Conference will also feature keynote presentations on novel investment modalities and effective partnerships in the era of open innovation. A series of breakout sessions will engage investors, entrepreneurs and technologists in a discussion about vital topics such as electromodulation and immunotherapeutics, equity crowdfunding, current venture investment trends and company valuation, and tapping angel investors for early-stage funding.
For more information about the Conference, including a detailed agenda, please visit the Southern California Biomedical Council’s Web site at www.socalbio.org.
The 15th SoCalBio Investor & Partnership Conference is sponsored by organizations dedicated to growing the life-science industry in Greater Los Angeles. The list of generous supporters includes:
- AMI – USC
- Perkins Coie
- Consulate General of Canada in Los Angeles
- Moss Adams
- Nixon Peabody
- Bench International
- Bolton & Company/Chubb
- Biotechnology Industry Organization
- California Community Colleges, Life Sciences/Biotech Industry Sector
- GXP Consulting
- LA BioMed
- LCS Constructors
- Pasadena Bioscience Collaborative
- Office Depot
About the Southern California Biomedical Council (SoCalBio):
The Southern California Biomedical Council is a nonprofit, member-supported trade association that supports and promotes life-science research, development, manufacturing, job creation and overall economic growth in the six counties of the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino).
The Council’s programs help local firms gain access to capital, potential partners and business support services. The annual SoCalBio Investor & Partnership Conference has grown to become the region’s premiere showcase for emerging life-science companies and technologies. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public at-large about the benefits of the region’s life-science industry.
SoCalBio is open to membership by firms and organizations engaged in life-science technology development and commercialization. More information is available at www.socalbio.org.